TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|
Cash flow from operating activities | |||
Earning before tax | 175.82%639.91M | 131.59%232M | ---734.46M |
Profit adjustment | |||
Interest (income) - adjustment | -98.72%-28.99M | 23.13%-14.59M | ---18.98M |
Investment loss (gain) | -166.53%-4.88M | -34.14%7.33M | --11.13M |
Impairment and provisions: | 186.56%71.87M | -97.57%25.08M | --1.03B |
-Impairmen of inventory (reversal) | 52.04%17.86M | -98.81%11.74M | --984.39M |
-Impairment of goodwill | ---- | --10.86M | ---- |
-Other impairments and provisions | 2,084.91%54.01M | -94.61%2.47M | --45.83M |
Revaluation surplus: | -490.10%-7.25M | -51.66%1.86M | --3.84M |
-Other fair value changes | -490.10%-7.25M | -51.66%1.86M | --3.84M |
Asset sale loss (gain): | 3,531.09%6.62M | 99.94%-193K | ---327.97M |
-Loss (gain) on sale of property, machinery and equipment | 323.32%431K | -201.05%-193K | --191K |
-Loss (gain) from selling other assets | --6.19M | ---- | ---328.16M |
Depreciation and amortization: | 31.43%204.86M | 111.10%155.87M | --73.84M |
-Amortization of intangible assets | -5.88%496K | -2.59%527K | --541K |
Financial expense | 25.39%90.72M | 133.92%72.35M | --30.93M |
Special items | ---- | ---7.49M | ---- |
Operating profit before the change of operating capital | 106.02%972.86M | 588.93%472.22M | --68.54M |
Change of operating capital | |||
Inventory (increase) decrease | -110.64%-37.1M | 183.18%348.69M | ---419.18M |
Accounts receivable (increase)decrease | -1,046.14%-351.37M | 127.22%37.14M | ---136.44M |
Accounts payable increase (decrease) | 144.95%104.97M | 55.57%-233.52M | ---525.57M |
prepayments (increase)decrease | -247.86%-69.69M | 1,369.46%47.14M | ---3.71M |
Special items for working capital changes | -258.03%-18M | 117.30%11.39M | ---65.82M |
Cash from business operations | -11.91%601.67M | 163.12%683.05M | ---1.08B |
Other taxs | 79.11%-15.31M | 33.68%-73.25M | ---110.46M |
Net cash from operations | -3.84%586.36M | 151.13%609.8M | ---1.19B |
Cash flow from investment activities | |||
Interest received - investment | 65.91%24.77M | -4.50%14.93M | --15.63M |
Dividend received - investment | 107.92%1.68M | --808K | ---- |
Decrease in deposits (increase) | 321.68%145.73M | 58.44%-65.74M | ---158.19M |
Sale of fixed assets | -57.56%1.89M | 1,300.31%4.45M | --318K |
Purchase of fixed assets | 3.80%-32.32M | -12.92%-33.6M | ---29.76M |
Purchase of intangible assets | ---- | ---- | ---32.68M |
Acquisition of subsidiaries | ---- | ---430.32M | ---- |
Recovery of cash from investments | -11.41%1.65B | -38.54%1.86B | --3.03B |
Cash on investment | 8.43%-1.58B | 33.23%-1.73B | ---2.58B |
Net cash from investment operations | 156.37%210.64M | -256.24%-373.67M | --239.16M |
Net cash before financing | 237.53%797M | 124.76%236.13M | ---953.48M |
Cash flow from financing activities | |||
New borrowing | -33.25%936.97M | -11.96%1.4B | --1.59B |
Refund | 35.85%-891.17M | -17.80%-1.39B | ---1.18B |
Issuing shares | ---- | ---- | --420M |
Interest paid - financing | -72.25%-66.73M | -67.60%-38.74M | ---23.11M |
Absorb investment income | --2.99M | ---- | --2.5M |
Issuance expenses and redemption of securities expenses | ---40.88M | ---- | ---- |
Other items of the financing business | -7,075.60%-430.54M | -136.07%-6M | --16.63M |
Net cash from financing operations | -389.99%-632.44M | -116.87%-129.07M | --765.28M |
Effect of rate | -7.33%2.42M | -9.35%2.61M | --2.88M |
Net Cash | 53.71%164.56M | 156.88%107.06M | ---188.2M |
Begining period cash | 20.57%642.86M | -25.79%533.2M | --718.52M |
Cash at the end | 25.97%809.84M | 20.57%642.86M | --533.2M |
Cash balance analysis | |||
Currency Unit | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS |
Audit Opinions | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |
Auditor | Deloitte Guan Huang Chen Fang Certified Public Accountants | Deloitte Guan Huang Chen Fang Certified Public Accountants | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.